M&A Deal Summary

Ergomed Acquires Ashfield Pharmacovigilance

On January 13, 2020, Ergomed acquired business services company Ashfield Pharmacovigilance from UDG Healthcare for 10M USD

Acquisition Highlights
  • This is Ergomed’s 1st transaction in the Business Services sector.
  • This is Ergomed’s 4th largest (disclosed) transaction.
  • This is Ergomed’s 1st transaction in the United States.
  • This is Ergomed’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2020-01-13
Target Ashfield Pharmacovigilance
Sector Business Services
Buyer(s) Ergomed
Sellers(s) UDG Healthcare
Deal Type Divestiture
Deal Value 10M USD

Target

Ashfield Pharmacovigilance

Durham, North Carolina, United States
Ashfield Pharmacovigilance, Inc. offers case management, global aggregate report development, literature search, risk management, signal surveillance activities, database, information technology, and pharmacovigilance consulting services.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ergomed

Guildford, United Kingdom
Category Company
Founded 1997
Sector Life Science
Employees1,371
Revenue 119M GBP (2021)
DESCRIPTION

Ergomed is a profitable UK-based business providing drug development services to the pharmaceutical industry and has a growing portfolio of co-development partnerships. It operates in over 50 countries. Ergomed provides clinical development, trial management and pharmacovigilance services to over 100 clients ranging from top 10 pharmaceutical companies to small and mid-sized drug development companies. Ergomed was founded in 1997 and is based in Guildford, the United Kingdom.

DEAL STATS #
Overall 6 of 8
Sector (Business Services) 1 of 2
Type (Divestiture) 1 of 1
State (North Carolina) 1 of 1
Country (United States) 1 of 2
Year (2020) 1 of 2
Size (of disclosed) 4 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-28 PSR Group B.V.

Hoofddorp, Netherlands

PSR Group B.V. is a full service specialist orphan drug CRO and recognised as a leading expert in the rare disease niche. PSR specialises in running complex orphan drug development programs requiring innovative regulatory and clinical approaches as well as pricing and reimbursement strategies. Besides outsourced project solutions, PSR provides insourced staffing solutions (orphan drug teams), temporary & permanent staffing, interim management solutions as well as training / coaching career programs.

Buy €6M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-14 MedSource

Houston, Texas, United States

MedSource is a specialized clinical research organization with a focus on complex diseases and study designs. MedSource delivers high-quality clinical trials specializing in oncology and rare disease. With over 20 years’ experience, MedSource has participated in more than 200 oncology and rare disease clinical trials. MedSource was founded in 1997 and is based in Houston, Texas.

Buy $16M

Seller(S) 1

SELLER

UDG Healthcare

Dublin, Ireland
Category Company
Founded 1948
Sector Business Services
Employees9,000
Revenue 1.3B USD (2020)
DESCRIPTION

UDG Healthcare operates in two segments, Ashfield and Sharp. Ashfield is a global integrated healthcare services partner offering a breadth of services in advisory, marketing, communications, strategic engagement, and patient solutions. Sharp engages in contract packaging, clinical, manufacturing, and technology services. UDG Healthcare was founded in 1948 and is based in Dublin, the Republic of Ireland.

DEAL STATS #
Overall 8 of 8
Sector (Business Services) 1 of 1
Type (Divestiture) 8 of 8
State (North Carolina) 1 of 1
Country (United States) 1 of 1
Year (2020) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-21 Putnam Associates

Boston, Massachusetts, United States

Putnam Associates is a consultancy focused on product commercialisation strategy, exclusively for the life sciences industry. Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world-class strategic advice based on sophisticated, robust analytics. Putnam Associates was founded in 1988 and is based in Boston, Massachusetts.

Buy $89M
Mergr

Product

Company

Legal